Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Personalized neurorehabilitation for stroke recovery

Official title: Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops

Run by University of Zurich · NCT06466772 · Data updated 2026-11-12

This study is testing a new personalized rehab approach to help stroke survivors improve their walking by using tailored feedback and sound therapy during sleep.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations1 site (Zurich, Canton of Zurich)
StatusRecruiting
StartedMarch 13, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJune 20, 2024
Trial IDNCT06466772 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have experienced an ischemic stroke or intracerebral hemorrhage with a gait deficit lasting between 30 days to 6 months.

Probably not a fit

Patients with significant cognitive impairment or those unable to adapt their gait voluntarily may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on improving gait recovery in stroke patients through precision neurorehabilitation. It integrates two innovative approaches: hyper-personalized feedback for lower limb motor rehabilitation and targeted auditory stimulation during sleep. The aim is to tailor rehabilitation methods to individual patient needs, addressing the variability in treatment responses. By employing these personalized techniques, the study seeks to enhance lower limb function and mobility in stroke survivors.

Why it matters

Potential benefit: If successful, this approach could significantly improve mobility and quality of life for stroke patients.

How similar studies have gone: While the concept of precision neurorehabilitation is emerging, this specific combination of personalized feedback and auditory stimulation is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ischemic stroke or intracerebral hemorrhage with a gait deficit older than 30 days but not more than 6 months.
* Functional Ambulation Category ≥3
* ≥18 years of age
* Informed consent as documented by signature

Exclusion Criteria:

* Cognitive impairment, Montreal Cognitive Assessment (MoCa) \< 20
* Comprehensive aphasia precluding the understanding of study-related information
* Previous stroke that caused sustained clinically relevant cognitive, visual and/or gait deficits
* Expected acute hospitalization during the training period
* History of a physical or neurological condition that interferes with study procedures
* Social and/or personal circumstances that interfere with the ability to return for therapy sessions and follow-up assessments
* Not capable of voluntary gait adaptation
* Allergy to nickel
* Patients taking benzodiazepines or Z-drugs with a significant effect on sleep EEG

Where it's running

  • University Hospital Zurich
    Zurich, Canton of Zurich, Switzerland
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.